The primary objective of the proposed research is to elucidate the clonal population structure and genetic relationships among unusually virulent strains of Streptococcus pyogenes, with special reference to organisms expressing pyrogenic exotoxin serotype A and/or C that very recently have been recovered in the United States and elsewhere from cases of toxic shock-like syndrome and other severe invasive diseases. Multilocus enzyme electrophoresis, which detects allelic variation in metabolic enzyme-encoding chromosomal genes, will be used to identify clones and assess overall chromosomal relatedness of pyrogenic exotoxin- expressing strains to isolates recovered from asymptomatic carriers, and other disease syndromes such as pharyngitis, glomerulonephritis, cellulitis, rheumatic fever, and scarlet fever. The second goal is to determine if pyrogenic exotoxin-expressing strains (especially those producing serotype M1 protein) recovered from patients in many European countries - where the increase in disease frequency and severity preceded that recorded in the United States - are clonally related to isolates recently causing toxic shock-like syndrome and other invasive diseases in this country. A third goal is to assess, at the molecular level, the extent to which horizontal transfer and recombination has contributed to the phylogenetic widespread occurrence of two related bacteriophage-borne pyrogenic exotoxin genes (speA and speC), and perhaps, to the origin of contemporary unusually virulent cell lineages. The genetic relationships among toxin-producing chromosomal genotypes revealed by multilocus enzyme electrophoresis will be used to provide a rational population genetic framework for relatively large-scale analysis of sequence divergence in speA and speC following amplification with the polymerase chain reaction. Data generated in the accomplishment of the third goal will be used to provide insight into the evolutionary forces molding the nature and extent of exotoxin sequence variation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI033119-01
Application #
3148232
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1991-12-01
Project End
1995-11-30
Budget Start
1991-12-01
Budget End
1992-11-30
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Reid, S D; Hoe, N P; Smoot, L M et al. (2001) Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions. J Clin Invest 107:393-9
Lukomski, S; Nakashima, K; Abdi, I et al. (2001) Identification and characterization of a second extracellular collagen-like protein made by group A Streptococcus: control of production at the level of translation. Infect Immun 69:1729-38
Kagawa, T F; Cooney, J C; Baker, H M et al. (2000) Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease. Proc Natl Acad Sci U S A 97:2235-40
Lukomski, S; Nakashima, K; Abdi, I et al. (2000) Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen. Infect Immun 68:6542-53
Mascini, E M; Jansze, M; Schellekens, J F et al. (2000) Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis 181:631-8
Gubba, S; Cipriano, V; Musser, J M (2000) Replacement of histidine 340 with alanine inactivates the group A Streptococcus extracellular cysteine protease virulence factor. Infect Immun 68:3716-9
Hoe, N P; Kordari, P; Cole, R et al. (2000) Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J Infect Dis 182:1425-36
Lukomski, S; Hoe, N P; Abdi, I et al. (2000) Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun 68:535-42
Hoe, N; Nakashima, K; Grigsby, D et al. (1999) Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains. Emerg Infect Dis 5:254-63
Stockbauer, K E; Magoun, L; Liu, M et al. (1999) A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins alphavbeta3 and alphaIIbbeta3. Proc Natl Acad Sci U S A 96:242-7

Showing the most recent 10 out of 44 publications